In an interview to CNBC-TV18, Surya Narayan Patra of PhillipCapital shared his readings and outlook on Sun Pharmaceutical Industries and also spoke about the warning letter which the company has received from USFDA.
first published: Dec 21, 2015 11:34 am
A collection of the most-viewed Moneycontrol videos.

Nifty Struggles Below 26,100 On Weekly F&O Expiry As Rupee Hits New Low| Closing Bell Live

Will Rupee Slide & Expiry Day Caution Keep Nifty Bulls On The Back Foot? | Opening Bell Live

Sensex, Nifty Retreat After Hitting Fresh Highs As Rupee Drops To Record Low| Closing Bell Live

Will Solid Q2 GDP Set The Ball Rolling For Nifty Bulls To Cross 26,300 Decisively?|Opening Bell Live
You are already a Moneycontrol Pro user.

